Table 2.
Electrocardiographic and echocardiographic measurements of the groups
| Severity of MIS-C | P value | Study Group | P value | |||
|---|---|---|---|---|---|---|
| Mild (n = 14) | Severe (n = 21) | MIS-C (n = 35) | Control (n = 36) | |||
| Electrocardiographic parameters | ||||||
| Heart rate (bpm) | 97.5 (79.0–125.0) | 100.0 (82.0–135.0) | 0.855a | 100.0 (81.0–135.0) | 83.0 (68.8–92.5) | < 0.001a |
| PR interval (msec) | 110.0 (96.3–125.0) | 120.0 (96.0–139.0) | 0.516a | 110.0 (99.0–138.0) | 120.0 (100.0–127.5) | 0.342a |
| QRS duration (msec) | 80.0 (78.0–100.0) | 80.0 (80.0–91.5) | 0.987a | 80.0 (80.0–96.0) | 82.5 (80.0–100.0) | 0.184a |
| QT interval (msec) | 350.0 (337.0–361.5) | 350.0 (345.0–370.0) | 0.434a | 350.0 (340.0–367.0) | 350.0 (350.0–387.5) | 0.282a |
| QTc (msec) | 410.0 (400.0–442.5) | 420.0 (390.0–445.0) | 0.960a | 420.0 (400.0–440.0) | 405.0 (390.0–430.0) | 0.143a |
| QTd (msec) | 93.5 (44.3–118.8) | 58.0 (45.0–115.0) | 0.677a | 69.0 (47.5–110.0) | 130.0 (105.0–140.0) | 0.014a |
| Echocardiographic parameters | ||||||
| LVEDD (mm) | 37.0 (29.8–42.3) | 39.0 (33.0–42.0) | 0.654a | 44.5 (38.3–46.8) | 39.0 (32.0–42.0) | 0.003a |
| EF (%) | 71.0 (66.8–75.3) | 65.0 (56.0–67.5) | 0.001a | 67.0 (62.0–71.0) | 67.5 (65.0–73.0) | 0.461a |
| FS (%) | 38.0 (35.8–44.3) | 35.0 (29.0–37.0) | 0.003a | 36.0 (33.0–38.0) | 38.0 (35.3–41.8) | 0.144a |
| Mitral E velocity (cm/sec) | 0.97 (0.87–1.00) | 0.90 (0.84–0.96) | 0.118a | 0.92 (0.86–0.98) | 0.99 (0.92–1.05) | 0.010a |
| Mitral A velocity (cm/sec) | 0.54 (0.48–0.60) | 0.48 (0.45–0.54) | 0.175a | 0.50 (0.46–0.56) | 0.56 (0.50–0.67) | 0.015a |
| E/A rate | 1.82 (1.52–1.90) | 1.88 (1.46–2.04) | 0.654a | 1.84 (1.51–1.96) | 1.71 (1.48–1.88) | 0.157a |
Values expressed as median (IQR)
EF Ejection fraction, FS Fractional shortening, LVEDD Left ventricle end diastolic dDiameter, MIS-C Multisystem Inflammatory Syndrome in Children, QTc Corrected QT interval, QTd QT dispersion
aMann-Whitney U Test